Clinical Trial Update: Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating bevacizumab in combination with chemotherapy for patients with previously untreated metastatic colorectal cancer that is unresectable.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Southern Italy Cooperative Oncology Group | Conditions: Colorectal Cancer | Phase 3 | Status: UNKNOWN